Skip to search formSkip to main contentSkip to account menu

incobotulinumtoxinA

Known as: BoNT-A 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (3)

Botulinum Toxin Type ANeuromuscular AgentsNeurotoxins
INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT

Narrower (3)

NT 201Xeominbocouture

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
Background We evaluated quality of life among subjects with upper- and lower-limb spasticity who received escalating doses of… 
2020
2020
One21: A Novel, Customizable Injection Protocol for Treatment of the Forehead with IncobotulinumtoxinA
: It is well known that incobotulinumtoxinA (INCO) is an effective approved treatment for dynamic wrinkles of the upper face… 
2019
2019
Long-term Safety and Efficacy of IncobotulinumtoxinA for the Treatment of Blepharospasm in Botulinum Toxin-naïve Subjects: Results of a Phase III Study (S28.005)
Objective: To assess the safety and efficacy of incobotulinumtoxinA for benign essential blepharospasm (BEB) in toxin-naive… 
2019
2019
Long-term Efficacy and Safety of IncobotulinumtoxinA Treatment for Sialorrhea (S4.007)
Objective: To assess the long-term efficacy and safety of incobotulinumtoxinA 75U and 100U in subjects with sialorrhea… 
Review
2016
Review
2016
IncobotulinumtoxinA: A Review in Upper Limb Spasticity
Intramuscular incobotulinumtoxinA (Xeomin®) is indicated for the treatment or improvement of adult patients with upper limb… 
2016
2016
A Double Blind Investigation of Efficacy and Safety of IncobotulinumtoxinA in Parkinson Disease Tremor- A Customized Injection Approach (S40.007)
2015
2015
A Prospective Rater- and Subject-Blinded Study Comparing the Efficacy of IncobotulinumtoxinA and OnabotulinumtoxinA to Treat Crow's Feet: A Clinical Crossover Evaluation
BACKGROUND Botulinum toxin A products have been used in aesthetics for more than 20 years. OBJECTIVE To compare… 
2014
2014
Quantitative evaluation of the onset and longevity of the action of incobotulinumtoxinA by skin displacement analysis in the treatment of glabellar frown lines.
BACKGROUND A quantitative numerical method for assessing the extent and duration of the inhibitory action of botulinum neurotoxin… 
2012
2012
First clinical experience of intravesical electromotive botulinum toxin administration for Painful Bladder Syndrome treatment.
Hypothesis / aims of study. Some trials has shown efficacy of injections of botulinum toxin A into the bladder wall (submucosally… 
2012
2012
Comparison of different preparations of botulinumtoxin
Background and Objectives: Botulinum neurotoxin A (BoNT-A) is the fi rst line treatment for cervical dystonia (CD). Three… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)